United States
I offer a unique fractional consultancy model designed to accelerate academic and early-stage biotech startups. My expertise provides a strategic blend of business acumen and traction, critical for increasing value and attracting investment. Core Service: Diligent start up incorporation, primary focus is on transforming academic innovations into viable, investor-ready enterprises. This involves a multi-tiered, milestone-driven approach that validates your technology and organizational structure for potential investors. Foundational Business Strategy Initial Due Diligence: A thorough assessment of the project's scientific merit, intellectual property landscape, and market potential. Strategically identify and engage with Key Opinion Leaders (KOL) and scientific advisors. This is crucial for building credibility and de-risking the project for investors. Stakeholder Alignment: Facilitate consensus among founders and key stakeholders on vision, mission, and long-term goals. Roadmap Development: Create a phased roadmap with clear, measurable milestones for drug discovery and development. Regulatory Pathway Planning: Develop a clear and compliant regulatory strategy from the outset, including early-stage liaison with authorities. Investment Readiness: Prepare the company for investor diligence by ensuring all foundational, regulatory milestones are clearly defined and defensible. The fractional retainer model allows a startup to gain access to skill set without the overhead of a full-time hire. By focusing on value-driving milestones, I not only advance the science validity but also build a compelling and secure business case for investment. I'm available to discuss how this fractional model can help you navigate the complexities of the biotech landscape and position your venture for success. Feel free to reach out: [email protected] or +1 689-777-0979.
🇸🇪 Navigating biotech growth as Business Developer at Astrid Pharma! The Swedish ecosystem is unmatched globally, driven by a unique model where researchers maintain 100% IP ownership. Backed by world-class support and institutions like the Karolinska Institutet. 🇸🇪🇺🇸 The future of precision medicine is being built right now. As Business Developer at Astrid Pharma, I am incredibly proud to see how we are leveraging the historic Sweden-US bilateral technology cooperation to accelerate breakthroughs on a global scale. #Biodefense #MedicalCountermeasures #BioSecurity #DualUseTech For us, AI in biotech isn't a passing trend—it is a decade-long commitment to turning the promise of precision medication into a daily reality for patients. #PrecisionMedicine #Oncology #AIinHealthcare #DeepTech My mission is our proprietary intellectual property. Pioneering BioCapZ, a revolutionary drug delivery system that integrates next-generation MRI Tracer technology and hyper-targeted oncology tumor site delivery. By bridging advanced AI diagnostics with localized therapeutics, we can actively track and treat aggressive cancers with visual accuracy and impact. Supported by Sweden’s unique 100% researcher IP ownership model, incubating at world-class Karolinska Institutet, and an influx of global capital, this ecosystem is proving to be unmatched. We are proud to lead the charge. 🚀 #Biotech #Sweden #Innovation #diversified-globalfunds
I’m incredibly proud to share a look into my recent work coordinating the on-site logistics for an advanced, multi-spot production for a world-recognized brand. Managing an activation of this scale takes more than just keeping a schedule—it requires a flawless live reality under intense, razor-thin timelines. By anchoring the central command on-site, I’ve added a powerful new layer to my operational skill set
At Ressaissi LLC, we're driven by a deep commitment to universal health and a passion for empowering biotech startups. We understand the intricate journey of bringing life-changing therapies to patients, and we're here to guide you every step of the way. We don't just consult; we collaborate, fostering constructive partnerships in the competitive biotech arena. Our unique perspective sets us apart. Having transitioned from patient advocacy within the industry to providing strategic guidance, we possess invaluable insight into the needs and challenges faced by both startups and established organizations. This experience allows us to anticipate roadblocks and develop effective solutions that accelerate your path to success. Partner with Ressaissi LLC and transform your vision into reality. Contact us today to discuss how we can help you bring your life-changing therapies to the world.
Client Engagement: Coca-Cola & FIFA Assignment: The Fan Mart (National Brand Activation & Soccer Culture Engagement) Location Coverage: Los Angeles, San Francisco, Seattle, Houston, Dallas, Kansas City, Miami, Atlanta, Philadelphia, Boston, and New York. The Labor Lead 1 of 6, the operational backbone of the "Fan Mart"—the flagship experiential footprint for Coca-Cola and FIFA. This is not a typical ambassador role; it is a high-stakes, multi-city deployment requiring elite logistical expertise. I will be responsible for translating the global prestige of the FIFA World Cup™ into a flawless, physical reality across 11 major U.S. markets. Operating at the intersection of the world’s largest beverage brand and the world’s premier sporting event, there is zero margin for error. Proving I am a professional who thrives under the pressure of high-visibility task execution, where precision is the only acceptable standard. Core Responsibilities - Advanced Logistical Orchestration: Mastermind the onsite flow, setup, and breakdown of "The Fan Mart," ensuring that every structural asset is positioned with surgical precision. - Lead Ambassador Authority: Direct and audit the performance of local teams across all 11 host cities. We are the final word on quality control and brand integrity. - High-Stakes Resource Management: Oversee the deployment of labor and materials in high-traffic, high-pressure environments, ensuring that the "Fan Mart" experience is consistently elite. - Accountability & Reporting: Serve as the primary liaison between field operations and executive stakeholders at Coca-Cola and FIFA, delivering flawless execution reports. - Strategic Leadership: The ability to command respect and maintain discipline among diverse labor teams in fast-paced, high-profile settings. - Operational Stamina: Readiness to navigate the intense travel schedule of a 11-city tour (West Coast, Central, and East Coast hubs).
Framework and implement Cooperative Research and Development Agreements (CRADAs). Instrumental in identifying, protecting, and commercializing our IP assets, with a focus on collaborative development and strategic partnerships .Experienced IP management professional specializing in CRADA development and technology transfer. Expertise includes IP strategy, patent prosecution, CRADA negotiation, licensing agreements for joint ventures, IP valuation, and market analysis for commercialization.
ReceptorPharma is an innovative organization with a focus on providing therapeutic solutions helping to improve the lives of patients. Our primary focus is Alzheimer with a novel mode of action. Our business idea is enabled by a very lean, ambitious, and motivated team with expertise and know-how within orphan receptors and early stage companies, in conjunction with global timing and quite a few dashes of serendipity. ReceptorPharma will actually have the opportunity to try to go after some of the largest crippling diseases that are plaguing the world, including Alzheimer’s, Parkinson’s and other neurodegenerative unmeet medical needs. Today, ReceptorPharma consists of founders from the classical giants of big pharma including almost 100 years of combined experience. These inventors are crucial as we filled the patents surrounding the most interesting and potential drug discovery substance in the last decade.
A sunny fall in 2017. Around the the mid of October apparently for no reason me and the other founder felt like Boot-straps process into the one of the money intense industries Biotechnology R&D was a good enough for us to prove a point. He was hatching plans for his big entry into the world of Biotech and i joined fearlessly. Well kind of a half-baked idea, to create a biotechnology company that worked a little differently with a less researched compound. A door knock later at Smile incubator and we got excepted in dec 2017 with a start in 2018. The accelerator program supported our journey and we started collaborations with the University and CRO's. This need to be descriped this way because the bullet points list where long and many it would show KPI's and prove the track record of results but the entrepreneurial spirit would have been lost in the tasks list.
3rd Generation biotech joining the future of better targeted therapy and enhancing the revolution of precision medication. We are a delivery system of the future in theraputics solutions. The BioCapZ Modular surface functionalization to carry targeting or tracking peptides, as well as immunogenic peptides for vaccine design. We have engineered the viral capsid to package many molecules, from small to large biological molecules such as proteins and nucleic acids (DNA and RNA). Strategic considerations of portfolio, the core responsibility that will be to lead project management efforts to support Chemistry Manufacturing & Controls (CMC) product development from First in Human to Transfer to Supply, driving line of sight across the development lifecycle and maintaining programs in harmony. In addition, expected to participate in development of tools and processes to support commercial readiness evaluation to portfolio management and increased integration of CMC strategies.
Pharmativalab will integrate the need of migration from Cannabis industry to Pharmaceutical compliance, including the educational model to transfer normal workers to be skilled workers in cGMP facilities utilising the the need of cannabinoids Pharma to prove its CMC developments and using Pharmativalab Farms for Biodynamic-Beta-Biomass production in small scale batches. US based vertical. Pharamtivalab created an African Initiative with the goal of accelerating our educational development, economic development, and job creation initiatives, as well as building on our current collaborations for research and multi-center clinical trials. Our African Initiative is flexible and is tailored to the specific conditions and requirements of each country, as determined by the people who live and work in the communities where we have operations. The collaboration with previously mining geographic for rejuvenation's has a UN and development bank of Africa as potential partners. Back by the green initiative for mining in Africa.